Thermo Fisher Scientific Inc (TMO): Today's Featured Health Services Winner

Thermo Fisher Scientific ( TMO) pushed the Health Services industry higher today making it today's featured health services winner. The industry as a whole closed the day up 0.4%. By the end of trading, Thermo Fisher Scientific rose $4.36 (8.8%) to $54.14 on heavy volume. Throughout the day, 5.7 million shares of Thermo Fisher Scientific exchanged hands as compared to its average daily volume of 2.1 million shares. The stock ranged in a price between $51.09-$54.33 after having opened the day at $51.09 as compared to the previous trading day's close of $49.78. Other companies within the Health Services industry that increased today were: Stereotaxis ( STXS), up 29.8%, Healthways ( HWAY), up 15.5%, BSD Medical Corporation ( BSDM), up 14.6%, and Sunshine Heart ( SSH), up 13.8%.

Thermo Fisher Scientific, Inc. provides analytical instruments, equipment, reagents and consumables, software, and services for research, manufacture, analysis, discovery, and diagnostics. Thermo Fisher Scientific has a market cap of $19.12 billion and is part of the health care sector. The company has a P/E ratio of 18.3, below the average health services industry P/E ratio of 18.8 and above the S&P 500 P/E ratio of 17.7. Shares are up 10.7% year to date as of the close of trading on Tuesday. Currently there are 12 analysts that rate Thermo Fisher Scientific a buy, no analysts rate it a sell, and two rate it a hold.

TheStreet Ratings rates Thermo Fisher Scientific as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, growth in earnings per share, attractive valuation levels, good cash flow from operations and expanding profit margins. We feel these strengths outweigh the fact that the company has had lackluster performance in the stock itself.

On the negative front, D Medical Industries ( DMED), down 19.2%, WellPoint ( WLP), down 12.1%, Health Net ( HNT), down 9.7%, and American Caresource Holdings ( ANCI), down 9.1%, were all laggards within the health services industry with Aetna ( AET) being today's health services industry laggard.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).

If you liked this article you might like

Jim Cramer: Agilent Technology Has Been One of My Favorites

Secondaries Get Primary Attention; Discerning Market -- Cramer's Top Thoughts

Cramer: Secondary Offerings Get Primary Attention

The Stock Market Is on Fire, Especially in These Sectors: Market Recon

PerkinElmer Among Targets Fitting Thermo Fisher's M&A Criteria